Decreased pigment epithelium-derived factor expression in human breast cancer progression

Jun Cai, Christian Parr, Gareth Watkins, Wen G. Jiang, Mike Boulton

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Purpose: The aim of this study was to correlate the expression of pigment epithelium - derived factor (PEDF), a potent endogenous antiangiogenic molecule, with severity and prognosis in breast cancer. Experimental Design: To investigate the gene expression profile of PEDF in human breast cancer in relation to a patient's clinical variables, we examined human breast cancer tissue (n = 119), background breast tissue (n = 33), and a range of cell lines for mRNA and protein levels of PEDF by using reverse transcription PCR, real-time quantitative PCR, immunohistochemistry, and ELISA. Results: By using reverse transcription PCR, real-time quantitative PCR, immunohistochemistry, and ELISA, PEDF expression was found to be dramatically decreased in breast cancer. An overall outlook for the patients inversely correlated with PEDF mRNA levels. Exogenous PEDF inhibits endothelial tubule formation induced by breast cancer cell - conditioned medium, in vitro. Conclusion: These observations collectively support the hypothesis that a lack of PEDF expression is a potent factor for the enhancement of tumor growth and angiogenesis in breast cancer.

Original languageEnglish (US)
Pages (from-to)3510-3517
Number of pages8
JournalClinical Cancer Research
Volume12
Issue number11 I
DOIs
StatePublished - Jun 1 2006
Externally publishedYes

Fingerprint

Breast Neoplasms
Reverse Transcription
Real-Time Polymerase Chain Reaction
Enzyme-Linked Immunosorbent Assay
Immunohistochemistry
Polymerase Chain Reaction
Messenger RNA
Conditioned Culture Medium
pigment epithelium-derived factor
Transcriptome
Breast
Research Design
Cell Line
Growth
Neoplasms
Proteins

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Decreased pigment epithelium-derived factor expression in human breast cancer progression. / Cai, Jun; Parr, Christian; Watkins, Gareth; Jiang, Wen G.; Boulton, Mike.

In: Clinical Cancer Research, Vol. 12, No. 11 I, 01.06.2006, p. 3510-3517.

Research output: Contribution to journalArticle

Cai, Jun ; Parr, Christian ; Watkins, Gareth ; Jiang, Wen G. ; Boulton, Mike. / Decreased pigment epithelium-derived factor expression in human breast cancer progression. In: Clinical Cancer Research. 2006 ; Vol. 12, No. 11 I. pp. 3510-3517.
@article{98420164a0c14b4685974e21f0ee67e0,
title = "Decreased pigment epithelium-derived factor expression in human breast cancer progression",
abstract = "Purpose: The aim of this study was to correlate the expression of pigment epithelium - derived factor (PEDF), a potent endogenous antiangiogenic molecule, with severity and prognosis in breast cancer. Experimental Design: To investigate the gene expression profile of PEDF in human breast cancer in relation to a patient's clinical variables, we examined human breast cancer tissue (n = 119), background breast tissue (n = 33), and a range of cell lines for mRNA and protein levels of PEDF by using reverse transcription PCR, real-time quantitative PCR, immunohistochemistry, and ELISA. Results: By using reverse transcription PCR, real-time quantitative PCR, immunohistochemistry, and ELISA, PEDF expression was found to be dramatically decreased in breast cancer. An overall outlook for the patients inversely correlated with PEDF mRNA levels. Exogenous PEDF inhibits endothelial tubule formation induced by breast cancer cell - conditioned medium, in vitro. Conclusion: These observations collectively support the hypothesis that a lack of PEDF expression is a potent factor for the enhancement of tumor growth and angiogenesis in breast cancer.",
author = "Jun Cai and Christian Parr and Gareth Watkins and Jiang, {Wen G.} and Mike Boulton",
year = "2006",
month = "6",
day = "1",
doi = "10.1158/1078-0432.CCR-06-0094",
language = "English (US)",
volume = "12",
pages = "3510--3517",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "11 I",

}

TY - JOUR

T1 - Decreased pigment epithelium-derived factor expression in human breast cancer progression

AU - Cai, Jun

AU - Parr, Christian

AU - Watkins, Gareth

AU - Jiang, Wen G.

AU - Boulton, Mike

PY - 2006/6/1

Y1 - 2006/6/1

N2 - Purpose: The aim of this study was to correlate the expression of pigment epithelium - derived factor (PEDF), a potent endogenous antiangiogenic molecule, with severity and prognosis in breast cancer. Experimental Design: To investigate the gene expression profile of PEDF in human breast cancer in relation to a patient's clinical variables, we examined human breast cancer tissue (n = 119), background breast tissue (n = 33), and a range of cell lines for mRNA and protein levels of PEDF by using reverse transcription PCR, real-time quantitative PCR, immunohistochemistry, and ELISA. Results: By using reverse transcription PCR, real-time quantitative PCR, immunohistochemistry, and ELISA, PEDF expression was found to be dramatically decreased in breast cancer. An overall outlook for the patients inversely correlated with PEDF mRNA levels. Exogenous PEDF inhibits endothelial tubule formation induced by breast cancer cell - conditioned medium, in vitro. Conclusion: These observations collectively support the hypothesis that a lack of PEDF expression is a potent factor for the enhancement of tumor growth and angiogenesis in breast cancer.

AB - Purpose: The aim of this study was to correlate the expression of pigment epithelium - derived factor (PEDF), a potent endogenous antiangiogenic molecule, with severity and prognosis in breast cancer. Experimental Design: To investigate the gene expression profile of PEDF in human breast cancer in relation to a patient's clinical variables, we examined human breast cancer tissue (n = 119), background breast tissue (n = 33), and a range of cell lines for mRNA and protein levels of PEDF by using reverse transcription PCR, real-time quantitative PCR, immunohistochemistry, and ELISA. Results: By using reverse transcription PCR, real-time quantitative PCR, immunohistochemistry, and ELISA, PEDF expression was found to be dramatically decreased in breast cancer. An overall outlook for the patients inversely correlated with PEDF mRNA levels. Exogenous PEDF inhibits endothelial tubule formation induced by breast cancer cell - conditioned medium, in vitro. Conclusion: These observations collectively support the hypothesis that a lack of PEDF expression is a potent factor for the enhancement of tumor growth and angiogenesis in breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=33745214608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745214608&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-06-0094

DO - 10.1158/1078-0432.CCR-06-0094

M3 - Article

VL - 12

SP - 3510

EP - 3517

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 11 I

ER -